Barclays
MGLN

Barclays’s Magellan Health Services, Inc. MGLN Stock Holding History

Barclays’s Portfolio MGLN Stock Details MGLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,300
Closed -$111K – 6468
2020
Q1 		$111K Buy
+2,300
New +$148K ﹤0.01% 4733
2019
Q4 		– Sell
-1,100
Closed -$68K – 7038
2019
Q3 		$68K Sell
1,100
-2,300
-68% -$153K ﹤0.01% 5745
2019
Q2 		$252K Buy
+3,400
New +$229K ﹤0.01% 4907
2017
Q4 		– Sell
-100
Closed -$9K – 7221
2017
Q3 		$9K Buy
+100
New +$7.88K ﹤0.01% 6205
2016
Q3 		– Sell
-3,600
Closed -$237K – 6890
2016
Q2 		$237K Hold
3,600
– – ﹤0.01% 3801
2016
Q1 		$241K Buy
+3,600
New +$217K ﹤0.01% 3711
2015
Q4 		– Sell
-1,000
Closed -$55K – 6792
2015
Q3 		$55K Buy
+1,000
New +$60.5K ﹤0.01% 4974
2014
Q2 		– Sell
-1,600
Closed -$94K – 7869
2014
Q1 		$94K Sell
1,600
-100
-6% -$5.96K ﹤0.01% 5507
2013
Q4 		$100K Buy
1,700
+1,300
+325% +$77.6K ﹤0.01% 5635
2013
Q3 		$24K Sell
400
-700
-64% -$40.6K ﹤0.01% 6458
2013
Q2 		$62K Buy
+1,100
New +$57.6K ﹤0.01% 6162

Barclays's MGLN Position: Q1 2022 in Review

Barclays sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 44,072 shares — an estimated $4.19M sold.

Barclays first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $5.28M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

  • Barclays reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
  • Barclays sold 44,072 Magellan Health Services, Inc. shares in Q1 2022, an estimated $4.19M.
  • Barclays first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
  • Barclays's Magellan Health Services, Inc. position peaked at $5.28M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.